
Opinion|Videos|July 29, 2024
Melanoma Research Beyond ASCO 2024: Upcoming Advances and Insights
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are the current challenges in translating clinical trial results into real-world practice for melanoma treatment? How can this process be streamlined?
- Please discuss any other data in melanoma released at ASCO 2024 that you find noteworthy to share with colleagues. (Please be prepared to discuss during the interview)
- Outside of ASCO 2024, what ongoing research efforts are you most excited for in the treatment and management of melanoma? What can we look forward to through the end of the year and beyond?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Cancer Care in Transition: Navigating Breakthrough Therapies Amid Economic Strain
4
Biktarvy Improves ART Persistence for People With HIV and Mental Health Disorders
5














































